JP Morgan Call 220 MRK 20.12.2024/ DE000JB4N1G9 /
2024-08-26 12:09:10 PM | Chg.+0.001 | Bid5:03:28 PM | Ask5:03:28 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.079EUR | +1.28% | 0.078 Bid Size: 7,500 |
0.110 Ask Size: 7,500 |
MERCK KGAA O.N. | 220.00 EUR | 2024-12-20 | Call |
GlobeNewswire
06-03
Biolojic Design Enters into a Multi-Target Drug Discovery Collaboration with Merck KGaA, Darmstadt, ...
GlobeNewswire
05-29
Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio fo...
GlobeNewswire
05-07
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire
05-06
Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire
03-04
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
2023-12-21
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
2023-12-14
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
2023-10-17
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA